TSX:CCO

Cameco Stock (CCJ) Weekend Update: Unusual Options Activity, Uranium Price Backdrop, and Analyst Targets Ahead of Monday’s Open

Cameco (NYSE: CCJ) closed Friday at $92.84, down $0.50, with Toronto shares at C$127.48. Unusual options activity saw put volume surge to 28,210 contracts, up 942% from average, according to MarketBeat. Uranium prices hovered near $81.40 per pound on Dec. 26, supporting sector sentiment. U.S. markets resume trading Monday.

27 December 2025

NYSE:CCJ·Stock Market·TSX:CCO

Cameco Stock (CCJ) Outlook on December 10, 2025: Can the Uranium Leader Sustain Its Nuclear and AI-Fueled Rally?

Cameco shares closed at $90.64 in New York on December 10, down for the day but up about 80% year-to-date and over 300% in four years. The uranium producer’s market cap stands near $41 billion, with a P/E above 100. Recent 13F filings show Intact and Guggenheim increasing stakes, while Ossiam and XTX Topco cut positions. Shares remain about 15% below their 52-week high.

10 December 2025

Artificial Intelligence·NYSE:CCJ·Stock Market·TSX:CCO

Canadian Stock Market Today (Nov. 25, 2025): TSX Hovers Near Record Highs on Fed Cut Bets, Barrick Deal and Uranium Talks

The S&P/TSX Composite Index closed up 0.31% at 30,698.51 on Tuesday, just below its record high, as investors anticipated a possible U.S. Federal Reserve rate cut in December. The TSX Venture Composite Index slipped 0.26% to 878.22. Barrick’s $430 million settlement with Mali and reports of a potential $2.8 billion uranium deal between Canada and India also drew market attention.

25 November 2025

Canadian Economy·Stock Market·TSX:ABX·TSX:CCO

Kennametal (KMT) Valuation Examined After Recent Share Price Decline
March 20, 2026, 3:19 AM EDT. Kennametal (KMT) shares fell about 9% last week and 10% over the month following a strong 22% gain in three months. Despite a 67.9% total shareholder return over one year, recent pullbacks raise questions on future growth prospects. The stock trades slightly below analyst targets but well below some intrinsic value estimates, with a fair value around $37.13 versus a $35.18 close. Cost-cutting efforts, including $125 million in expected savings by fiscal 2028, aim to improve margins. However, risks include persistent weak demand and potential delay in realizing efficiencies. Investors should weigh these factors carefully amid mixed market signals and consider alternative industrial exposure opportunities.